In HNSCC, TMEM16A has been shown to enhance tumor proliferation via the RAS-RAF-ERK-CCND1 pathway9, and a decrease in TMEM16A expression via promoter methylation has been implicated in a shift of HNSCC activity from tumor growth toward metastatic spread11. This evidence concerns the gene ANO1 and neoplasm.